Chronic food restriction increases fos-like immunoreactivity (FLI) induced in rat forebrain by intraventricular amphetamine.
Chronic food restriction enhances behavioral responsiveness to amphetamine and other abused drugs. Because this effect is evident when drugs are administered intracerebroventricularly (i.c.v.) as well as systemically, it would seem to reflect increased sensitivity of a neural substrate rather than a change in drug disposition. In the present study, c-Fos immunohistochemistry was used to evaluate whether the magnitude and pattern of cellular activation induced by i.c.v. amphetamine is altered by a regimen of food restriction previously shown to potentiate amphetamine reward. In the absence of amphetamine challenge, there was generally no difference in brain Fos-like immunoreactivity (FLI) between ad libitum fed and food-restricted rats. In response to amphetamine (50 microg), both groups displayed increased FLI in caudate-putamen, nucleus accumbens, bed nucleus of the stria terminalis, ventral pallidum, central nucleus of the amygdala, and cingulate cortex. With the exception of cingulate cortex and caudal caudate-putamen, a significantly greater response was observed in brain regions of food-restricted rats. These results indicate that food restriction augments a cellular immediate early gene (IEG) response to acute amphetamine in brain regions known to mediate rewarding and other behavioral effects of psychostimulants. The difference between these results and those produced by sensitizing regimens of psychostimulant exposure are discussed, as are possible endocrine factors that could be involved in the modulatory effect of food restriction on cellular and behavioral responses to amphetamine.
Carr
K D
KD
Millhauser Laboratories, Department of Psychiatry, New York University, School of Medicine, New York, NY 10016, USA. kc16@is4.nyu.edu
Kutchukhidze
N
N
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D005508:Food Deprivation / Q000502:physiology*; D016762:Genes, fos / Q000187:drug effects* / Q000502:physiology; D006179:Gyrus Cinguli / Q000187:drug effects / Q000378:metabolism; D008297:Male; D016548:Prosencephalon / Q000187:drug effects* / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
D000697:Central Nervous System Stimulants; D016760:Proto-Oncogene Proteins c-fos; D000661:Amphetamine